Search

everythinglearnresearchcommunity

for

Search:↓

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hair transplantation effectively treats burn scar alopecia, improving self-esteem and confidence.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.